You just read:

MEI Pharma Presents Phase 1b Clinical Data for ME-401 in Patients with Indolent B-Cell Malignancies at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

News provided by

MEI Pharma, Inc.

Jun 04, 2018, 08:01 ET